Generate Biomedicines Ownership | Who Owns Generate Biomedicines?
Generate Biomedicines Ownership Summary
Generate Biomedicines is owned by 78.19% institutional investors, 14.05% insiders, and 7.76% retail investors. Flagship pioneering is the largest institutional shareholder, holding 48.89% of GENB shares. American Funds SMALLCAP World A is the top mutual fund, with 2.92% of its assets in Generate Biomedicines shares.
GENB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Generate Biomedicines | 78.19% | 14.05% | 7.76% |
| Sector | Financial Services Stocks | 493.55% | 13.79% | -407.34% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Flagship pioneering | 62.67M | 48.89% | $783.41M |
| Fmr | 7.19M | 5.60% | $107.94M |
| Capital world investors | 4.20M | 3.28% | $63.11M |
| Braidwell lp | 3.59M | 2.80% | $44.91M |
| Jpmorgan chase | 2.65M | 2.07% | $40.94M |
| Vanguard capital management | 2.24M | 1.74% | $33.58M |
| Price t rowe associates inc /md/ | 2.11M | 1.65% | $26.37M |
| Ark investment management | 1.96M | 1.53% | $29.51M |
| Arch venture management | 1.94M | 1.52% | $24.31M |
| Blackrock funding, inc. /de | 1.83M | 1.43% | $27.49M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Flagship pioneering | 62.67M | 67.44% | $783.41M |
| Harbourvest partners | 1.72M | 16.69% | $25.87M |
| Arch venture management | 1.94M | 3.59% | $24.31M |
| Davern capital partners, lp | 824.68K | 2.41% | $12.39M |
| Braidwell lp | 3.59M | 1.50% | $44.91M |
| Prosight management, lp | 144.76K | 0.42% | $2.17M |
| Sphera funds management | 185.00K | 0.37% | $2.31M |
| Siren | 736.10K | 0.26% | $11.06M |
| Ark investment management | 1.96M | 0.17% | $29.51M |
| Neo ivy capital management | 33.88K | 0.11% | $508.95K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Flagship pioneering | 62.67M | 67.44% | 62.67M |
| Braidwell lp | 3.59M | 1.50% | 3.59M |
| Price t rowe associates inc /md/ | 2.11M | 0.00% | 2.11M |
| Fmr | 7.19M | 0.00% | 1.96M |
| Arch venture management | 1.94M | 3.59% | 1.94M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Harvard management | - | - | -1.11M |
| Alyeska investment group | - | - | -500.00K |
| Exoduspoint capital management, lp | - | - | -311.99K |
| Affinity asset advisors | 100.00K | 0.06% | -300.00K |
| Sixth street partners management company | - | - | -224.60K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Flagship pioneering | 62.67M | 67.44% | 62.67M | $783.41M |
| Braidwell lp | 3.59M | 1.50% | 3.59M | $44.91M |
| Price t rowe associates inc /md/ | 2.11M | 0.00% | 2.11M | $26.37M |
| Arch venture management | 1.94M | 3.59% | 1.94M | $24.31M |
| Baker bros. advisors lp | 1.42M | 0.10% | 1.42M | $17.80M |
Sold Out
| Holder | Change |
|---|---|
| Caitong asset management | -1.00 |
| Hollencrest capital management | -5.00 |
| Benson wealth management | -363.00 |
| Fny investment advisers | -3.00K |
| Strs ohio | -4.80K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 88 | 51.72% | 100,275,833 | 8.03% | 78 | 1.49% | 68 | 17.24% | 10 | - |
| Mar 31, 2026 | 28 | - | 10,533,115 | - | 8 | - | 28 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.75M | 2.92% | - |
| Fidelity Growth Company Fund | 2.19M | 1.70% | 1.34M |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.89M | 1.47% | 1.07M |
| ARK Genomic Revolution ETF | 1.64M | 1.28% | 9.46K |
| T. Rowe Price Health Sciences | 1.02M | 0.80% | -765.57K |
| Fidelity Growth Compy Commingled Pl S | 989.76K | 0.77% | 141.50K |
| ARK Genomic Revolution | 833.27K | 0.65% | 358.32K |
| Vanguard Total Stock Mkt Idx Inv | 816.88K | 0.64% | 720.00K |
| Vanguard Morn Total Stk Mkt Idx Investor | 816.88K | 0.64% | 720.00K |
| Fidelity Growth Company K6 | 695.89K | 0.54% | 459.85K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 29, 2026 | ARNOLD FRANCES | - | Sell | $184.73K |
| Sep 01, 2026 | ARNOLD FRANCES | - | Sell | $16.00K |
GENB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools